Trial Profile
Use of Methylene Blue in Acquired Methemoglobinemia: Prospective Observational Registry (metHb)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Apr 2023
Price :
$35
*
At a glance
- Drugs Methylthioninium chloride (Primary)
- Indications Methaemoglobinaemia
- Focus Therapeutic Use
- Acronyms metHb
- 10 Apr 2023 Status changed from active, no longer recruiting to completed.
- 07 Jul 2021 Planned End Date changed from 1 Oct 2020 to 31 Aug 2021.
- 07 Jul 2021 Status changed from recruiting to active, no longer recruiting.